Home Search
geovax - search results
If you're not happy with the results, please do another search
Op-Ed: Why the US Must Move Beyond Its mRNA Monoculture
BioPharm
David Dodd, GeoVax Labs (NASDAQ: GOVX), opines on why vaccine platform diversity is critical in the United States.
Editor's Note: The views an opinions expressed...
China and the US Fighting a Battle for Biotech Dominance
An Expert from GeoVax (GOVX) Discusses how China may be Poised to Overtake the US as the World Leader in the Industry.
MBGA
John Crowley,...
Happy News! GSK (GSK) Just Paid $367 Million, for Synvidia’s Pre-Clinical Trial Cancer Treatment.
One of the Fun Features of Biotech Investing, is Getting Paid on a Treatment That Hasn't Even Entered Clinical Trials.
A lot of investors...
TWO DOUBLES, From the Same Stock! Bavarian Nordic (BVRNY) $12.25, gains 149% After Adding...
Been quite sometime since we had Watch List company taken out, at over $1 Billion but here we go again. With our 4th billion...
We Have “Natural Kill Cell.” Interview with Dr. Patrick Soon-Shiong.
Adding ImmunityBio (IBRX) $2.40 to Watch List.
You never know where you'll find a great idea (potentially great that is). How's Megyn Kelly for...
Vaccine Biotechs Hammered After FDA Official Resigns, Citing RFK Jr.’s ‘Misinformation And Lies’ (IBD)
Sorting Through the Wreckage!
Full post on Investor's Business Daily.
Biotech stocks took a beating Monday after Peter Marks, a top Food and Drug Administration official,...
Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.
Can You Imagine Selling Solgenix at $2.00 yesterday.
And to be honest, news wasn't all that big - such as FDA approval. What the reported...
FDA approves Amgen drug for tough-to-treat form of lung cancer.
Known scientifically as tarlatamab, Indelltra is only for patients once they progress following chemotherapy. On chemotherapy alone, patients can expect to live on average...
Ardelyx (ARDX) Reports First Quarter 2024 Showing $204 Million in Cash!
When we added Ardelyx (ARDX) to the Watch List in November of 2022, the market cap near $80 million. Now it's approaching $2...
NovaVax (NVAX) Roars Higher, Gaining 225% a $1.2 Billion Increase, at the Blink of...
Sanofi (SNY) Announces Partnership - $500 Million Upfront, plus $700 million in Milestones with NovaVax (NVAX). And some investors say Covid is gone -...
Latest article
National Investment Bankers Conference
Companies Scheduled to Present
Since 1982, The National Investment Banking Association (NIBA) has been serving the micro-cap and small-cap investment community. They have hosted 150...
Report: Sekur Private Data (SWISF) Awarded Place on GSA Schedule.
This Week's GSA Announcement Marks Sekur’s 4th Major Milestone.
GSA Approval is akin to an electrician just starting out in the business, and being told...
Halted Stocks Watch List
We are following Companies which have been suspended by the SEC and will update news related to them here. In near real time.
To...
